<p>(A) Western blotting of eNOS, sGCα1 and sGCβ1, (B) densitometric analysis of sGCα1/β-actin, (C) densitometric analysis of sGCβ1/β-actin, (D) densitometric analysis of eNOS/β-actin and (E) concentration of cGMP, in lung tissue of different treatment groups. *<i>p</i><0.05. <i>Note.</i> eNOS, endothelial nitric oxide synthase; PDE-5, phosphodiesterase type 5; sGCα1, soluble guanylate cyclase α1; sGC, soluble guanylate cyclase; sGCβ1, soluble guanylate cyclase β1; cGMP, cyclic guanosine monophosphate.</p
Airway inflammation with mucus overproduction is a distinguishing pathophysiological feature of many...
Sildenafil, a phosphodiesterase 5 inhibitor, is currently under investigation for therapy of pulmona...
<p><b>A</b>: Western Blot analysis of eNOS Ser<sup>1177</sup> phosphorylation. Means ± S.E. (n = 4)....
The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signal-t...
<p>Riociguat significantly increased cGMP concentration in hyperoxia-exposed rats as compared with p...
<p>(A) Western blotting of caspase-3 and cleaved caspase-3 with densitometric analysis and (B) PCNA ...
<p>(A) Proportion of non-, partially or fully muscularized pulmonary arteries as a percentage of the...
Sildenafil, an oral phosphodiesterase Type 5 inhibitor, has vasodilatory effects through a cGMP-depe...
Sildenafil, a selective and potent inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosp...
Introduction Current treatment with vasodilators for pulmonary hypertension associated with respirat...
Phosphodiesterase (PDE)-5 degrades guanosine 3',5'cyclic monophosphate (cGMP) and its inhibitor sild...
<p>Nitrocellulose based rat cytokine array assay was performed on lung homogenates of untreated (Sha...
Background: Presence of pulmonary hypertension (PH) and right ventricular dysfunction worsens progno...
A direct pharmacological stimulation of soluble guanylate cyclase (sGC) is an emerging therapeutic a...
A direct pharmacological stimulation of soluble guanylate cyclase (sGC) is an emerging therapeutic a...
Airway inflammation with mucus overproduction is a distinguishing pathophysiological feature of many...
Sildenafil, a phosphodiesterase 5 inhibitor, is currently under investigation for therapy of pulmona...
<p><b>A</b>: Western Blot analysis of eNOS Ser<sup>1177</sup> phosphorylation. Means ± S.E. (n = 4)....
The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signal-t...
<p>Riociguat significantly increased cGMP concentration in hyperoxia-exposed rats as compared with p...
<p>(A) Western blotting of caspase-3 and cleaved caspase-3 with densitometric analysis and (B) PCNA ...
<p>(A) Proportion of non-, partially or fully muscularized pulmonary arteries as a percentage of the...
Sildenafil, an oral phosphodiesterase Type 5 inhibitor, has vasodilatory effects through a cGMP-depe...
Sildenafil, a selective and potent inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosp...
Introduction Current treatment with vasodilators for pulmonary hypertension associated with respirat...
Phosphodiesterase (PDE)-5 degrades guanosine 3',5'cyclic monophosphate (cGMP) and its inhibitor sild...
<p>Nitrocellulose based rat cytokine array assay was performed on lung homogenates of untreated (Sha...
Background: Presence of pulmonary hypertension (PH) and right ventricular dysfunction worsens progno...
A direct pharmacological stimulation of soluble guanylate cyclase (sGC) is an emerging therapeutic a...
A direct pharmacological stimulation of soluble guanylate cyclase (sGC) is an emerging therapeutic a...
Airway inflammation with mucus overproduction is a distinguishing pathophysiological feature of many...
Sildenafil, a phosphodiesterase 5 inhibitor, is currently under investigation for therapy of pulmona...
<p><b>A</b>: Western Blot analysis of eNOS Ser<sup>1177</sup> phosphorylation. Means ± S.E. (n = 4)....